Crossmark

Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data

Crossref DOI link: https://doi.org/10.1007/s00213-017-4573-1

Published Online: 2017-03-07

Published Print: 2017-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Herring, W. Joseph

Connor, Kathryn M.

Snyder, Ellen

Snavely, Duane B.

Zhang, Ying

Hutzelmann, Jill

Matzura-Wolfe, Deborah

Benca, Ruth M.

Krystal, Andrew D.

Walsh, James K.

Lines, Christopher

Roth, Thomas

Michelson, David
Funding

Funding for this research was provided by:

Merck
License Information

License valid from 2017-03-07